Antiphospholipid antibodies and digestive tract disease;Les anticorps antiphospholipides en pathologie digestive

Presse Medicale

Volumn 30, Issue 38, 2001, Pages 1890-1897

  Braham, A ^a   Safer, L ^a   Bdioui, F ^a   Lejmi, A ^a   Brahmi, I ^a   Ben Chabenne, N ^a   Ben Mimoun, H ^a   Saffar, H ^a  

^a Service de Gastro Hepato Enterologie   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ALCOHOL LIVER CIRRHOSIS; ANTIPHOSPHOLIPID SYNDROME; BUDD CHIARI SYNDROME; CLINICAL EXAMINATION; DISEASE ASSOCIATION; GASTROINTESTINAL DISEASE; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER HYPERPLASIA; MESENTERIC VEIN THROMBOSIS; MYELOPROLIFERATIVE DISORDER; NODULAR HYPERPLASIA; PORTAL VEIN THROMBOSIS; PROGNOSIS; REVIEW; THROMBOGENESIS;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; CELIAC DISEASE; COLITIS; COLITIS, ULCERATIVE; CROHN DISEASE; DIGESTIVE SYSTEM DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOCAL NODULAR HYPERPLASIA; HEPATIC VEIN THROMBOSIS; HEPATITIS C; HEPATITIS, ALCOHOLIC; HUMANS; INFLAMMATORY BOWEL DISEASES; LIVER; LIVER CIRRHOSIS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER DISEASES; LIVER TRANSPLANTATION; PREVALENCE; RISK FACTORS; THROMBOSIS;

EID: 0035893332     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Les anticorps antiphospholipides
2. Antiphospholipid syndrome. The clinican's point of view
3. Quels critères pour le diagnostic du syndrome des antiphospholipides?
4. Quelle est la nature des lésions vasculaires du syndrome des antiphospholipides?
5. Antiphospholipid antibodies in a healthy population: Methods of estimating the distribution
6. Antiphospholipid antibodies and thrombosis. A consequence, coincidence, or cause?
7. Influence of disease duration, continued follow-up and further antiphospholipid testing on the frequency and classification category of antiphospholipid syndrome in a cohort of patients with systemic lupus erythematous
8. Anti endothelial cell antibodies in patients with the antiphospholipid syndrome
9. Lupus anticoagulants: Leur place au laboratoire d'hémostase
10. Interference de l'excés de facteur VIII sur la détection des lupus anticoagulants par le temps de céphaline activé
11. Antiphospholipid antibodies and the antiphospholipid syndrome
12. Association of anti-β2glycoprotein I antibodies with lupus type circulating anticoagulant and thrombosis in systemic lupus erythematosus
13. Analytical and clinical relationships between human IgG auto-antibodies to b2·glycoprotein I and anticardiolipin antibodies
14. Antibodies to phospholipid free β2-glycoprotein I in patients with primary antiphospholipid syndrome
15. Anomalies de l'hémostase et entéropathies chroniques inflammatoires. Quelles perspectives?
16. Prévalence et rôle des anticorps anticardiolipine dans la maladie de Crohn
17. Prevalence and significance of anticardiolipin antibodies in Crohn's disease
18. Anticorps antiphospholipides dans les maladies inflammatoires chroniques du tube digestif
19. Increased anticardiolipin antibodies in patients with inflammatory bowel disease
20. Anticardiolipin antibodies in inflammatory bowel diseases
21. Antiphospholipid antibodies in inflammatory bowel disease
22. Role of interleukin I in inflammatory bowel disease-enchanced production during active disease
23. Platelet procoagulant activity: Physiological significance and mechanism of exposure
24. Endothélium, thrombose et fibrinolyse
25. Epidémiologie et génétique des maladies inflammatoires chroniques de I'intestin
26. The « primary » antiphospholipid syndrome: Major clinical and serological features
27. Association maladie coeliaque et syndrome des antiphospholipides
28. Anomalies de I'he〈mostase au cours des he〈patopathies
29. The hepatic complications of the antiphospholipid antibodies
30. Antiphospholipid antibodies in patients with chronic hepatitis C virus infection or alcoholic liver disease
31. Anticorps sériques anticardiolipines chez les malades atteints de cirrhose alcoolique
32. Phospholipid antibodies in alcoholic liver disease
33. Lupus anticoagulant in liver cirrhosis
34. Frequent difficulties encountered in the laboratory diagnosis of antiphospholipid-protein antibodies
35. Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients
36. Portal thrombosis in cirrhotics
37. Anticardiolipin antibodies in chronic hepatitis C: Implication of hepatitis C virus
38. Prevalence et signification des autoanticorps anti-cardiolipides au cours de I'hépatite virale chronique C
39. Hepatitis C virus, antiphospholipid antibodies, thrombosis
40. Virus de I'hépatite C et auto-immunité: Un lien qui reste à établir
41. Increased rate of thrombin generation in hepatitis C virus cirrhotic patients. Relationship to venous thrombosis
42. The developpement of antiphospholipid antibodies in hemophilia is linked to infection with hepatitis C
43. Human immunodeficiency virus rather than hepatitis C virus infection in relevant to the development of an anti-cardiolipin antibody
44. Antiphospholipid syndrome as the second cause of non tumorous Budd-Chiari syndrome
45. Budd-Chiari syndrome in young patients with anticardiolipin antibodies: Need for prolonged anticoagulant treatment
46. Thrombose portale révélant un syndrome des antiphospholipides. Deux cas
47. Portal and hepatic vein thromboses: Concurrence of multiple prothrombotic states and focal factors
48. Thrombose porte, infarctus mésentérique et anticorps anticardiolipine au cours d'un SIDA
49. Primary antiphospholipid syndrome as cause of intestinal infarction
50. Gastrointestinal hemorrhage and intestinal ischemia associated with anticardiolipin antibodies
51. Hyperplasie nodulaire régénérative associée à un syndrome primaire des antiphospholipides
52. Antiphospholipid antibodies may play a role in the pathogenis of nodular regenerative hyperplasie of the liver
53. An acquired-pseudo Bernard Soulier syndrome occuring with auto-immune chronic hepatitis and anti-cardiolipin antibody
54. Interféron alpha et auto-immunité
55. Apparition d'anticorps anti-phospholipides chez les patients présentant une hépatite virus C, traitée par interféron-α
56. High prevalence of anti-phospholipid antibodies and anti-thyroglobulin antibody in patients with hepatitis C virus infection treated with interfeνron-α
57. Anticardiolipin antibody associated cerebral infarction in cirrhosis: Clearance of anticardiolipin antibody after liver transplantation
58. Management of the antiphospholipid sydrome. Main trends, involved questions, practical and educational aspects
59. Syndrome des antiphospholipides. Un traitement mieux codifié
60. The management of thrombosis in the antiphospholipid-antibody syndrome
61. Anticorps antiphospholipides: Limites et utilisation potentielle au cours des maladies du foie